IMPLANT SITE NECROSIS

This adverse event was reported 88 times

IMPLANT SITE NECROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CARMUSTINE 4 0.0008
1 ZICONOTIDE ACETATE 2 0.0008
2 CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2 0.0007
3 ETONOGESTREL 32 0.0006
4 TRABECTEDIN 1 0.0004
5 LEVOLEUCOVORIN INJECTION 1 0.0003
6 BACLOFEN INJECTION 1 0.0003
7 CALCITONIN SALMON 1 0.0003
8 LEVOLEUCOVORIN 1 0.0003
9 CYCLOBENZAPRINE HYDROCHLORIDE 2 0.0002
See all drugs enriched for association with IMPLANT SITE NECROSIS

IMPLANT SITE NECROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Calcitonin [EPC] 1 0.0003
1 Androgen [EPC] 5 0.0002
2 Asparagine-specific Enzyme [EPC] 2 0.0001
3 Vitamin D2 Analog [EPC] 1 0.0001
4 Progestin [EPC] 32 0.0001
5 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 2 0.0001
6 Vitamin D Analog [EPC] 1 0.0001
7 gamma-Aminobutyric Acid-ergic Agonist [EPC] 4 0.0000
8 Catecholamine [EPC] 3 0.0000
9 Alkylating Drug [EPC] 7 0.0000
See all drug classes enriched for association with IMPLANT SITE NECROSIS